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Management of the critically ill pregnant woman is
complicated by potential adverse effects of both
maternal illness and ICU interventions on the fetus. This
paper reviews the potential risks to the fetus of maternal
critical illness, including shock, hypoxemia, and fever, as
well as the effects of critical care management, such as
drug therapy and radiological investigations. The
authors’ recommended approach to management is
provided. Prior publications and new data presented
identify that there is insufficient information to
prognosticate accurately on fetal outcome after maternal
critical illness, although maternal shock, hypoxemia and
early gestational age are likely significant risk factors.as placental perfusion (and therefore oxygen delivery)Introduction
Management of the critically ill pregnant patient is com-
plicated by the presence of the fetus. The fetus is at risk
from the effects of the maternal illness as well as from the
effects of critical care interventions. Altering maternal
care to protect the fetus (for example, avoiding certain
drugs or radiological investigations) may have deleterious
effects on both mother and fetus. Limited data exist to
identify fetal risk factors in critically ill mothers admitted
to the ICU. This article reviews the potential adverse ef-
fects of maternal critical illness on the fetus, as well as the
limited data available to predict fetal outcome. We provide
data from a secondary analysis of a database of critically ill
pregnant women. The potential dilemma of termination of
pregnancy to improve maternal well-being is also addressed.Potential effects of critical illness on the fetus
Shock
Shock may occur in the pregnant patient as a result of
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2014Pregnancy results in dramatic changes to the uterine cir-
culation, with a marked increase in blood flow, related to
an overall increase in maternal cardiac output and a re-
duction in resistance of the vascular bed of the uteropla-
cental circulation [1]. Placental circulation is unique in
having no capillary microcirculation but a high flow, low
resistance system of spiral arteries. The uteroplacental vas-
cular bed is usually maximally dilated, but has a strong
alpha-adrenergic receptor system with a marked decrease
in uteroplacental blood flow in response to endogenous or
exogenous stimulation [1]. Normal maternal hemodynamic
responses to hypotension are therefore not protective of
the fetus, but rather protect maternal vital organs, shifting
cardiac output from the uterine and placental circulation to
the maternal brain and heart. Fetal oxygenation decreases
decreases [2].
In the critically ill pregnant patient, several hemodynamic
factors may potentially adversely affect the fetus. These
include maternal shock (for example, sepsis, hemorrhage,
pulmonary embolism) or hypotension due to sedative
drugs or positive pressure ventilation. Although beneficial
in reversing maternal hypotension, the use of sympatho-
mimetic agents may reduce placental perfusion. Alpha-
adrenergic agents directly vasoconstrict the uteroplacental
vascular bed and beta-adrenergic agents dilate other vas-
cular beds, shunting blood away from the uterus [1]. Clin-
ical data on the use of these agents is limited, although
animal studies provide some information. Norepinephrine,
epinephrine and dopamine have all been shown to reduce
uterine blood flow [3]. Ephedrine and phenylephrine have
been used for maternal hypotension secondary to neurax-
ial anesthesia, in small bolus doses or by infusion. Phenyl-
ephrine is currently the preferred option [4,5]. Left lateral
tilt of the hypotensive pregnant women should always be
considered as an early intervention, to reverse a supine
hypotensive effect [6]. Our practice with regard to vaso-
pressor use in pregnancy is to follow our usual protocols
(that is, most commonly norepinephrine with or without
dobutamine) after adequate fluid resuscitation and left
lateral positioning. In consultation with the obstetric teaml Ltd. The licensee has exclusive rights to distribute this article, in any medium,
this time, the article is available under the terms of the Creative Commons
rg/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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utilized to identify whether these infusions are producing
beneficial or adverse effects on the fetus.
Hypoxemia
Oxygen delivery to the fetus is dependent on utero-
placental blood flow and blood oxygen content. Fetal
oxygenation is precarious with partial pressure of oxygen
in the umbilical vein (returning from the placenta to the
fetus) of about 28 mmHg [7]. The oxygen delivery to fetal
organs is increased by the left-shifted oxygen dissociation
curve of fetal hemoglobin and high fetal cardiac output.
As described in the section above, maternal shock will sig-
nificantly reduce the oxygen delivery to the placenta and
fetus. Maternal hypoxia causes hypoxic fetoplacental vaso-
constriction, reducing placental flow and reducing fetal
oxygen transfer [8]. A decrease in maternal oxygen satu-
ration is likely to cause a significant drop in fetal oxygen
delivery [7]. A theoretical model based on animal studies
suggests that a decrease in maternal arterial oxygen satu-
ration from 96% to 85% would be associated with a de-
crease in fetal umbilical vein oxygenation from about 70%
to 55% [7]. If the oxygen content of fetal blood is reduced
(even by up to 50%), compensation can occur as the fetus
redirects cardiac output to the fetal heart and brain [9]. A
further drop in oxygen content results in anerobic metab-
olism and if oxygen delivery is reduced by more than 75%,
central nervous system damage may ensue.
Reliable human data are not available to confirm the po-
tential adverse effects of acute maternal hypoxia on the
fetus. A study in non-critically ill pregnant women gener-
ated transient maternal hypoxemia (mean saturation
<85%) by inhalation of 10% oxygen. Redistribution of ma-
ternal blood flow was noted favoring the maternal brain,
but no adverse effects were noted on fetal monitoring
[10]. A report of six pregnant women admitted to the ICU
with severe acute respiratory distress syndrome (ARDS)
describes maternal oxygen saturations initially in the range
of 50 to 88% [11]. Despite aggressive ICU care there were
only two good neonatal outcomes, with three intrauterine
or neonatal deaths and one neonate surviving with
hypoxic-ischemic encephalopathy. However, although aut-
opsy in one neonate confirmed multiorgan hypoxic injury,
other insults to the fetus may have played a role. A corre-
lation between the degree of maternal hypoxemia and fetal
outcome was not demonstrated.
Our practice is to aim for a maternal oxygen saturation
greater than 92% when possible, although evidence to sup-
port this threshold is lacking. Consideration needs to be
given to the potential adverse effects of such a cutoff - for
example, the higher positive end-expiratory pressure
(PEEP) required may decrease cardiac output and ad-
versely affect placental blood flow. In the presence of
severe ARDS with intractable hypoxemia, considerationmay be given to delivery in collaboration with the obstetri-
cian, if this is considered beneficial to the fetus (see also
the section below, ‘Terminating pregnancy for ‘maternal
well-being’’).
Fever
The management of fever is not always considered essen-
tial in the stable ICU patient, and may be harmful in pa-
tients with sepsis [12]. However, for pregnant patients,
high body temperature may have adverse structural and
functional effects on the fetus. A number of fetal effects
have been described, which include neurological (includ-
ing autism) as well as craniofacial and cardiac defects [13].
The limited data available do not permit identification of a
clear temperature threshold for risk. Fetal risk increases
linearly with duration of the elevated temperature and
exponentially with the degree of temperature elevation, an
elevation of 2°C above normal for 24 hours likely confer-
ring risk [13]. Fever should be rapidly treated with antipyr-
etic agents (for example, acetominophen) and external
cooling.
Cardiac arrest
The frequency of cardiac arrest in pregnancy varies from
1 in 20,000 to 1 in 50,000 pregnancies [14,15]. The limited
cardiac output provided by cardiopulmonary resuscitation
(CPR) may have devastating effects on the fetus.
The usual management of cardiac arrest requires some
modification in the pregnant patient, particularly related
to patient positioning and emergency cesarean delivery
[16]. Aortocaval compression by the gravid uterus may ad-
versely affect maternal hemodynamics; this occurs from
approximately 20 weeks gestation [16]. Manual uterine
displacement to the left while maintaining supine position
is better than left-lateral tilt in terms of optimizing the
quality of CPR [16,17]. Emergency cesarean section may
have dramatic beneficial effects on maternal hemodynamics
and may be life-saving for the fetus (if viable). If return of
spontaneous circulation does not occur by 4 minutes of
resuscitative efforts, or if the mother has sustained an
obviously non-survivable injury, immediate emergency
cesarean delivery should be considered [18]. Optimally,
delivery should occur within 5 minutes of cardiac arrest.
Relief of aortocaval compression after the uterus has been
emptied can result in a 60 to 80% increase in maternal
cardiac output [19]. One review evaluated emergent
cesarean deliveries for pregnant women with cardiac
arrest and identified several case reports, including 38
cases in total, in which 34 infants (25 to 42 weeks gesta-
tion) survived and 4 other infants survived initially, but
died several days later from complications of prematurity
and anoxia [18]. Notably, 9 of 12 infants delivered within
5 minutes had a normal neurological outcome, although
neonatal outcome was not reported for the other three
Table 1 Risk of fetal radiation exposure resulting from
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tially reversible conditions, of whom 13 were discharged
home in good condition. In no cases was there a deterior-
ation in maternal condition related to the cesarean section,
and in many a dramatic improvement in hemodynamic
status was noted.
Potential effects of ICU management on the fetus
Drug therapy
The potential risks of vasoactive drugs on placental perfu-
sion have been described in the section on maternal shock
above. Despite these potential effects, maintenance of ma-
ternal blood pressure with these agents may be essential
for maternal and fetal survival.
Teratogenicity concerns should not influence drug
therapy in the critically ill mother, although the clinical
team should be cognizant of the concerns of family
members in this regard. The risk of teratogenesis for the
fetus in normal pregnancy is approximately 1 to 3% [20].
The risk is highest in the first trimester, and observa-
tional studies have investigated the risk of fetal terato-
genicity in first trimester exposure of pregnant women
to surgery and anesthesia [21,22]. No increased risk of
fetal teratogenesis was observed, but the exposure to
sedatives and analgesics was limited to a short period in
the operating room.
Evidence to support decisions regarding sedation and
analgesia in the ICU is limited, and no guidelines are
available. An increased risk of cleft lip and plate with
benzodiazepine use in early pregnancy has been demon-
strated in an animal model [23], but has not been con-
firmed in humans [24]. Of the benzodiazepines, transfer
to the fetus is likely lowest with midazolam [25]. Most
sedatives, including propofol and thiopental, can de-
crease blood pressure and therefore utero-placental
blood flow. A single report describes two cases of acid-
osis occurring in pregnant women undergoing a pro-
longed infusion of propofol for neurosurgical procedures
[26]. Opioids, including morphine and fentanyl, have not
been associated with fetal teratogenicity. Although most
non-depolarizing agents can cross to the placenta, they
are unlikely to have a clinical impact on the fetus. The
concentration ratio between the umbilical vein and
maternal vein for muscle relaxants ranges from 7 to 26%
[27].
Our practice with regard to sedation and analgesia in
the pregnant woman is similar to the non-pregnant pa-
tient, utilizing an approach with which we have signifi-
cant experience in the non-pregnant patient. We utilize
a protocol based on a sedation scale to minimize drug
use [28], using fentanyl for analgesia and midazolam for
sedation, when required. It is important to plan for
neonatal respiratory depression in the event of delivery
in the sedated mother.Radiological investigations
Radiologic investigations are often essential for the
evaluation and management of the critically ill pregnant
patient. While there are potential risks of exposing the
fetus to ionizing radiation, maternal recovery is essential
for fetal well-being, and appropriate radiologic proce-
dures should not be avoided [29]. Fetal exposure may be
reduced by shielding the abdomen with lead and using a
well-collimated X-ray beam. Estimated fetal radiation
exposure can be limited to safe levels for most procedures
using these techniques, although investigations such as
abdominal-pelvic computed tomography (CT) cannot
avoid significant fetal radiation exposure (Table 1) [29,30].
The adverse effects of exposure of the fetus to radiation
include oncogenicity and teratogenicity. A doubling of the
risk of childhood leukemia may result from fetal exposure
in the range of 20 to 50 mGy (2 to 5 rads). Most ICU in-
vestigations can be carried out well below these levels of
exposure to the fetus (Table 1). Teratogenicity appears to
occur at higher radiation doses, in the range of 50 to
100 mGy (5 to 10 rads). Recently, Ray and colleagues
[31] conducted a population-based study of 1.8 million
maternal-child pairs to investigate the association
between fetal exposure to CT and radionuclide imaging,
and the risk of childhood cancer. The absolute annual
risk of childhood malignancy is about 1 in 10,000, and
the risk did not appear to be increased following in utero
radiation exposure (hazard ratio 0.68; 95% confidence
interval 0.25 to 1.80).
In the critically ill mother, radiological investigations
should be performed as required, and not withheld if there
is a likelihood of benefitting the mother. Every effort
should nonetheless be made to minimize uterine expo-
sure, particularly in the first trimester. Chests X-rays are
performed as required (but not as a routine; for example,
not daily) and chest CT when required for diagnosis of
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enchyma. In the relatively rare situation of intrabdominal
catastrophe, CT of the abdomen and pelvis may be neces-
sary, despite the clear risk of fetal exposure.
Fetal monitoring
Continuous electronic monitoring of fetal heart rate
(FHR) can be used to identify changes in fetal physiology
as reflected by normal or abnormal fetal heart rate pat-
terns [31]. Abnormal patterns of FHR have been identified
that have good sensitivity but varying specificity for fetal
distress. Fetal tachycardia often occurs in the presence of
maternal infection or chorioamnionitis, but more omin-
ous is the finding of fetal bradycardia or sinusoidal vari-
ation in FHR, which may suggest fetal hypoxia. In the
event of spontaneous labor, the FHR changes during uter-
ine contractions may be informative; early decelerations
imply bradycardia coinciding with contractions, and are
benign. In contrast, repetitive late decelerations, with
bradycardia beginning beyond the peak in contraction and
persisting after the contraction, may be a sign of fetal
compromise, particularly if associated with a reduced
beat-to-beat variation. This abnormal fetal physiology is
usually a result of uteroplacental or fetal pathology, but in
the critically ill mother may result from maternal hypox-
emia or reduced cardiac output producing reduced uter-
ine oxygen delivery. FHR monitoring requires expertise to
interpret, and appropriate obstetric support if delivery is
warranted on the basis of suspected fetal compromise.
Our practice is to perform intermittent monitoring (for
example, every 12 hours) by an obstetric nurse. In some
situations, continuous monitoring is performed, with the
continuous presence of an obstetric nurse to allow inter-
pretation and prompt and appropriate intervention.
Ultrasound-based biophysical profile evaluation provides
another method of fetal assessment [32]. Ultrasound is
used to evaluate factors such as spontaneous movement,
breathing action, and amniotic fluid volume. A normal
biophysical profile usually carries a good prognosis.
The biophysical profile can be supplemented with fetal
Doppler studies of the umbical artery as well as the fetal
middle cerebral artery. Results from fetal Doppler help to
guide decisions around intervention for fetal compromise.
Fetal outcome after maternal critical illness
In a systematic review of 40 studies of pregnant and
postpartum women admitted to the ICU, the proportion
of patients who were pregnant on ICU admission was me-
dian 16% (interquartile range (IQR) 6 to 28%) [33]. Peri-
natal mortality was reported inconsistently, but data were
available in 22 of the studies, with a median mortality of
20% (IQR 11 to 32%). Only one study to date has specific-
ally evaluated fetal prognostic predictors in this patient
group, and assessed only patients with non-obstetricalcauses for ICU admission at a single center [34]. In 93
pregnant women, 32 fetal losses occurred with 10 neo-
nates requiring ICU care. Multivariable logistic regression
analysis identified three factors associated with fetal loss,
namely maternal shock (odds ratio 6.85), maternal trans-
fusion of blood products (odds ratio 7.24) and lower ges-
tational age (odds ratio 1.2 per week less than 37).
We performed a secondary analysis of 30 pregnant pa-
tients requiring intensive care, extracted from a database
of 332 pregnant and postpartum patients who were at
more than 12 weeks gestation, and admitted to the ICU
for more than 24 hours [35]. The definition of fetal death
in this database included only deaths occurring from the
time of the mother’s ICU admission to hospital discharge.
Thirty pregnant patients (9% of the 332 patients in the
database) were identified, comprising 24 patients in whom
the fetus survived and 6 patients in whom the fetus died.
The characteristics of the mothers of the fetuses who
survived were compared with those of fetuses that died,
with respect to clinical data. Sixty-four variables were
compared between the two groups and no adjustment was
made for the number of tests done. Data are summarized
by median and IQR for continuous data and by frequen-
cies and proportions for categorical variables. Fisher’s
exact test and Wilcoxon rank-sum test were used and
P < 0.05 was considered statistically significant. SAS sys-
tem version 9.1 for Windows (SAS Institute, Inc., Cary,
NC, USA) was used to analyze the data.
Almost all patients (90%) were admitted to ICU with
medical conditions. Seventeen of these patients (56%)
delivered during their ICU stay. Two women died in the
ICU (7%), one from hypoxic respiratory failure due to
pneumonia and Churg-Strauss syndrome, and the other
due to septic shock. Both maternal deaths were pre-
ceded by fetal death. Underlying maternal conditions
and maternal and fetal outcome are shown in Table 2.
Half of the 30 patients required ventilatory support and
two of four patients with shock required inotrope sup-
port. Nine patients (30%) had preterm delivery. Partial
thromboplastin time was significantly lower, and length
of stay in ICU was significantly longer in the group with
fetal mortality (Table 3). Several parameters, including
lower gestational age, maximum temperature, low alkaline
phosphatase, low serum bicarbonate and high Acute Physi-
ology and Chronic Health Evaluation II showed a trend to-
wards association with fetal mortality, but not reaching
statistical significance. No difference was found for some
parameters considered important a priori, namely oxygen-
ation, blood pressure and hemoglobin level.
The previously published data and our analysis dem-
onstrate that there is insufficient evidence to confidently
prognosticate with regard to fetal outcome in the critic-
ally ill pregnant woman. Maternal shock and lower
gestational age are clear risk factors, and although not
Table 2 Characteristics and outcome of mothers and neonates
ICU admission







Respiratory Churg-Strauss, asthma, pneumonia, pneumothorax,
ARDS
12 4 3 1
Neurological SAH, intracerebral hemorrhage, TBI, seizure 7 3 3 1
Infectious Pyelonephritis, pneumonia 6 0 0 0
Cardiac Hypertensive crisis 3 1 0 0
Hematological Lymphoma 1 1 0 0
Liver Fulminant hepatic failure 1 0 0 0
ARDS, acute respiratory distress syndrome; SAH, subarachnoid hemorrhage; TBI, traumatic brain injury.
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likely carries an additional risk.
Terminating pregnancy for ‘maternal well-being’
Due to the effects of respiratory physiological changes of
late pregnancy and the fetal demands for oxygen con-
sumption and carbon dioxide excretion, delivery of the
pregnant patient with respiratory failure may result in im-
provement in the mother’s condition [36]. However, data
from small case series addressing this issue have not con-
sistently demonstrated a significant benefit to the mother,
and delivery carries a risk of harm [37,38]. Although some
degree of improvement in oxygenation has been noted
[36], this is not associated with improvement in respira-
tory system compliance or PEEP level [37]. Delivery
should therefore not be performed purely in the hope of
improving maternal condition, at the expense of the fetus.Table 3 Comparison of maternal clinical parameters and labo
Variables Fetus survived, media
Age (years) 25.5 (19.5-3
Gestational age (weeks) 30.5 (25.5-3
Gravity 1 (0–1.5
APACHE II 12.5 (7.5-1
GCS 15 (14–1
Maximum temperature (celsius) 37.5 (36.8-3
Minimum systolic blood pressure (mmHg) 107 (103–1
Minimum diastolic blood pressure (mmHg) 58 (55–6
P/F ratio 238 (178–3
A-a DO2 164 (62–2
Alkaline phosphatase (U/L) 160 (99–2
Hgb (g/dL) 96.5 (85–10
Bicarbonate (mmol/L) 22 (18.0-2
PTT (seconds) 28.7 (25.9-3
Hospital LOS (days) 7.5 (7–1
ICU LOS (days) 2 (2–4)
A-a DO2, alveolar-arterial oxygen difference; APACHE, Acute Physiology and Chronic
tile range; LOS, length of stay; P/F, partial pressure of oxygen to fraction of inspiredHowever, if the fetus is at a viable gestation but is at risk
due to severe maternal hypoxia, consultation with the
perinatal team may identify a benefit to the fetus of early
delivery. Obstetric indications should determine the mode
of delivery. While cesarean section allows more rapid de-
livery in the critically ill patient, the increased physio-
logical stress of operative delivery may carry increased
risks for the mother.
Conclusion
The fetus of a critically ill pregnant women is at risk of ad-
verse effects related to both the maternal illness as well as
the ICU treatment and interventions. Data on these risks
are limited, but from the underlying physiology, animal
studies and limited human case series, several factors likely
contribute, namely maternal shock, hypoxemia and fever,
drug therapy, radiological investigations, lower gestationalratory results during first 24 hours of ICU admission
n (IQR) (N = 24) Fetus died, median (IQR) (N = 6) P-value
3.0) 24.0 (19.0-28.0) 0.46
5.5) 20.5 (18.0-29.0) 0.05
) 0 (0–1) 0.31
4.0) 15.5 (13.0-21.0) 0.08
5) 12 (7–15) 0.13
8.1) 38.6 (37.6-39.5) 0.07
18) 108 (88–110) 0.80
8) 69 (61–70) 0.41
75) 190 (177–292) 0.44
36) 172 (127–374) 0.27
51) 57.5 (44.5-91.5) 0.05
5.5) 91 (74–97) 0.28
3.6) 18.5 (15.5-20.1) 0.06
2.4) 20.6 (16.6-24.5) 0.03
1) 11 (9–31) 0.25
7.5 (5–9) <0.002
Health Evaluation; GCS, Glasgow coma scale; Hgb, hemoglobin; IQR, interquar-
oxygen ratio; PTT, partial thromboplastin time.
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to stress that interventions and drugs essential to treat the
critically ill mother should not be withheld due to concern
for their potential adverse effects on the fetus.
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